BODE Index: A Predictor of COPD Exacerbation

Journal Title: Journal of Medical Science And clinical Research - Year 2018, Vol 6, Issue 11

Abstract

Introduction: The severity of COPD (chronic obstructive pulmonary disease) is often graded using parameter like Forced Expiratory Volume (FEV1). The BODE (body mass index, degree of airflow obstruction, dyspnea grading and exercise testing) index is a multi-dimensional tool taking into account body mass index, severity of obstruction, dyspnea grading and 6MWT (six minute walk test) to assess severity of COPD. Objective: To study BODE index as a predictor of risk of exacerbation for improving COPD outcome. Materials and Methods: We conducted a prospective study over a period of 2 years, on 60 stable COPD patients by evaluating the body-mass index, spirometry, Modified Medical Research Council (mMRC) dyspnea scale and 6MWT and categorizing into mild, moderate and severe COPD cases on the basis of spirometry and into 4 quartiles on the basis of BODE index value (scores 0-2, 3-4, 5-6 and 7-10). We investigated the prognostic value of BODE quartiles for both the number and severity of exacerbations requiring ambulatory treatment, emergency room visit or hospitalization. Results: In our study, spirometry showed mild obstruction in 16.7%, moderate obstruction in 26.7%, severe obstruction in 38.3% and very severe obstruction in 18.3% of patients. According to BODE score 52% of patients were quartile 1, 21% quartile 2, 15% quartile 3 and 12% were quartile 4. There was a significant relation between BODE index and COPD severity (p < 0.001). In our study, 8.3% patients had no exacerbation; maximum number of exacerbation were 7 observed in 8.3 % patients and 21.7% of patients had 3 exacerbations in 2 years and 16.7% patients had 1 exacerbation in 2 years. It was observed that higher the BODE index; greater is the severity of COPD and more are the number of exacerbations. Conclusion: BODE index should be calculated in every COPD patients for better prediction of risk of exacerbation, hospitalization and for judicious referral of patients with COPD, thereby preventing the wastage of the limited resources available.

Authors and Affiliations

Dr P. Prabhudesai

Keywords

Related Articles

A Study on C Reactive Protein - Morbidity Predictor in Ischaemic Stroke

Background: With an annual incidence of 0.2 to 2.5 per 1000 population, CVA is an important health problem worldwide. Though ischaemic CVA is one of the leading causes for death and disability, parameters for predicting,...

Analgesic Activity of Asoka – Saraca asoca (Roxb.) de Wilde

The drug, Asoka – Saraca asoca (Roxb.) de Wilde. has been included under Vedanasthapana Mahakashaya mentioned in Shatvirechana shatasriteeya by Acharya Charaka. Analgesic activity of drug has been mentioned in the classi...

Tranexamic Acid - Evaluation of its use in Decreasing Blood Loss and Transfusion in Knee Arthroplasty

Background: Peri-operative bleeding is one of the major indication for allogenic blood transfusion. To reduce Post-operative blood loss, a number of antifibrinolytic agents like tranexamic acid have been used, which act...

A Study to Assess the Prevalence of Overweight and Obesity among the Employees of Public Sector Offices of Gwalior City

Introduction: According to the World Health Organization (WHO), obesity is one of the most common, yet among the most neglected, public health problems in both developed and developing countries. Employees working in cer...

The Study of Physiological Variations in Electrocardiogram in Late Adolescent

To assess the prevalence of physiological variations & abnormal changes 100 electrocardiograms were recorded of asymptomatic late adolescents (16-19years). This suggests that physiological variations have basis of altera...

Download PDF file
  • EP ID EP507230
  • DOI -
  • Views 80
  • Downloads 0

How To Cite

Dr P. Prabhudesai (2018). BODE Index: A Predictor of COPD Exacerbation. Journal of Medical Science And clinical Research, 6(11), 393-400. https://www.europub.co.uk/articles/-A-507230